Related references
Note: Only part of the references are listed.Parkinson's disease age at onset genome-wide association study: Defining heritability, genetic loci, and α-synuclein mechanisms
Cornelis Blauwendraat et al.
MOVEMENT DISORDERS (2019)
Targeting Huntingtin Expression in Patients with Huntington's Disease
Sarah J. Tabrizi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
GBA1-associated parkinsonism: new insights and therapeutic opportunities
Emory Ryan et al.
CURRENT OPINION IN NEUROLOGY (2019)
New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics
S. Pablo Sardi et al.
PARKINSONISM & RELATED DISORDERS (2019)
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
M. D. Benson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Progression in the LRRK2-Asssociated Parkinson Disease Population
Rachel Saunders-Pullman et al.
JAMA NEUROLOGY (2018)
Genetic Forms of Parkinson's Disease
Christine Y. Kim et al.
SEMINARS IN NEUROLOGY (2017)
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Ganqiang Liu et al.
ANNALS OF NEUROLOGY (2016)
Survival and dementia in GBA-associated Parkinson's disease: The mutation matters
Roberto Cilia et al.
ANNALS OF NEUROLOGY (2016)
A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis
Nir Giladi et al.
FRONTIERS IN NEUROLOGY (2016)
Interest in Genetic Testing in Ashkenazi Jewish Parkinson's Disease Patients and Their Unaffected Relatives
Manisha Gupte et al.
JOURNAL OF GENETIC COUNSELING (2015)
Knowledge of and Interest in Genetic Results Among Parkinson Disease Patients and Caregivers
Karina Sakanaka et al.
JOURNAL OF GENETIC COUNSELING (2014)
Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease
Roy N. Alcalay et al.
JAMA NEUROLOGY (2014)
Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2013)
Cognitive performance of GBA mutation carriers with early-onset PD The CORE-PD study
R. N. Alcalay et al.
NEUROLOGY (2012)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset
Z. Gan-Or et al.
NEUROLOGY (2008)
Share Paper
